BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9872610)

  • 1. Transarterial chemoembolization and percutaneous ethanol injection therapy in patients with hepatocellular carcinoma.
    Kirchhoff T; Chavan A; Galanski M
    Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):907-9. PubMed ID: 9872610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
    Dettmer A; Kirchhoff TD; Gebel M; Zender L; Malek NP; Panning B; Chavan A; Rosenthal H; Kubicka S; Krusche S; Merkesdal S; Galanski M; Manns MP; Bleck JS
    World J Gastroenterol; 2006 Jun; 12(23):3707-15. PubMed ID: 16773687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma.
    Kamada K; Kitamoto M; Aikata H; Kawakami Y; Kono H; Imamura M; Nakanishi T; Chayama K
    Am J Surg; 2002 Sep; 184(3):284-90. PubMed ID: 12354601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
    Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
    Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis.
    Tanaka K; Nakamura S; Numata K; Kondo M; Morita K; Kitamura T; Saito S; Kiba T; Okazaki H; Sekihara H
    Cancer; 1998 Jan; 82(1):78-85. PubMed ID: 9428482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma.
    Kato T; Saito Y; Niwa M; Ishiguro J; Ogoshi K
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S115-8. PubMed ID: 8137469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.
    Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H
    Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization.
    Tanaka K; Nakamura S; Numata K; Okazaki H; Endo O; Inoue S; Takamura Y; Sugiyama M; Ohaki Y
    Radiology; 1992 Nov; 185(2):457-60. PubMed ID: 1329143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate.
    Lencioni R; Paolicchi A; Moretti M; Pinto F; Armillotta N; Di Giulio M; Cicorelli A; Donati F; Cioni D; Bartolozzi C
    Eur Radiol; 1998; 8(3):439-44. PubMed ID: 9510580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
    Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA
    Asian Pac J Cancer Prev; 2016; 17(9):4349-4352. PubMed ID: 27797242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival of Taiwanese patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection.
    Li YH; Wang CS; Liao LY; Wang CK; Shih LS; Chen RC; Chen PH
    J Formos Med Assoc; 2003 Mar; 102(3):141-6. PubMed ID: 12783129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
    Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
    Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.
    Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY
    Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma.
    Becker G; Soezgen T; Olschewski M; Laubenberger J; Blum HE; Allgaier HP
    World J Gastroenterol; 2005 Oct; 11(39):6104-9. PubMed ID: 16273634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.